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participate.Management of Vascular Access in Transcatheter Aortic Valve Replacement:
Part 2: Vascular Complications767Stefan Toggweiler, Jonathon Leipsic, Ronald K. Binder, Melanie Freeman, Marco Barbanti,
Robin H. Heijmen, David A. Wood, John G. Webb
Vascular complications are one of the limiting factors when using large sheaths and
catheters required for percutaneous aortic valve replacement. Initially, a surgical
cutdown was used to obtain access to the femoral or iliac artery, but more recently,
percutaneous techniques have emerged as the new standard, resulting in a fully
percutaneous procedure. To increase the safety and efﬁcacy of the procedure, it is
important to understand the frequency, causes, and treatment options of vascular
complications.CLINICAL RESEARCH Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable
Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based
Sirolimus-Eluting Stents in Patients With Coronary Artery Disease:
Final 5-Year Report of the LEADERS (Limus Eluted From A Durable Versus
ERodable Stent Coating) Randomized, Noninferiority Trial777Patrick W. Serruys, Vasim Farooq, Bindu Kalesan, Ton de Vries, Pawel Buszman, Axel Linke,
Thomas Ischinger, Volker Klauss, Franz Eberli, William Wijns, Marie Claude Morice,
Carlo Di Mario, Roberto Corti, Diethmar Antoni, Hae Y. Sohn, Pedro Eerdmans,
Tessa Rademaker-Havinga, Gerrit-Anne van Es, Bernhard Meier, Peter Jüni, Stephan Windecker
The LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating)
trial is the ﬁrst randomized study to evaluate biodegradable (BES) against durable
(SES) polymer drug-eluting stents and has concluded its ﬁnal 5 years follow-up.
The BES was noninferior to SES for the primary endpoint (cardiac death,
myocardial infarction [MI], or clinically indicated target vessel revascularization)
(186 [22.3%] vs. 216 [26.1%], rate ratio [RR]: 0.83 [95% conﬁdence interval (CI):
0.68 to 1.02], p for noninferiority <0.0001, p for superiority ¼ 0.069). The BES
was associated with a signiﬁcant reduction in the patient-oriented composite
endpoint of all-cause death, any MI, and all-cause revascularization (297 [35.1%]
vs. 339 [40.4%], RR: 0.84 [95% CI: 0.71 to 0.98], p for superiority ¼ 0.023).See additional content in the online version of this issue.(continued on A-25)
august 2013
volume 6, no. 8
A-25Enhanced Mortality Risk Prediction With a Focus on High-Risk Percutaneous
Coronary Intervention: Results From 1,208,137 Procedures in the NCDR
(National Cardiovascular Data Registry)790J. Matthew Brennan, Jeptha P. Curtis, David Dai, Susan Fitzgerald, Akshay K. Khandelwal,
John A. Spertus, Sunil V. Rao, Mandeep Singh, Richard E. Shaw, Kalon K. L. Ho,
Ronald J. Krone, William S. Weintraub, W. Douglas Weaver, Eric D. Peterson,
on behalf of the National Cardiovascular Data Registry
Using data from 1,208,137 PCI procedures at 1,252 CathPCI Registry partici-
pating sites, we sought to: 1) assess the association between clinical instability and
in-hospital mortality following percutaneous coronary intervention (PCI) in
contemporary practice; and 2) evaluate the performance of the updated Version 4
CathPCI Registry data clariﬁcation form (DCF v4) mortality models across the
spectrum of procedural risk. Despite apparent improvements in survival in the
setting of high-risk PCI, periprocedural clinical instability remains a powerful
predictor of in-hospital mortality. With the inclusion of indicators for high-risk
PCI, the updated CathPCI Registry DCF v4 mortality models perform well in both
low- and high-risk PCI patient populations.JACC: Cardiovascular Interventions CME is available online.
Go to http://interventions.onlinejacc.org/ to participate.Incidence, Predictors, Morphological Characteristics, and Clinical Outcomes of
Stent Edge Dissections Detected by Optical Coherence Tomography800Daniel Chamié, Hiram G. Bezerra, Guilherme F. Attizzani, Hirosada Yamamoto,
Tomoaki Kanaya, Gregory T. Stefano, Yusuke Fujino, Emile Mehanna, Wei Wang,
Ahmad Abdul-Aziz, Matthew Dias, Daniel I. Simon, Marco A. Costa
High-resolution optical coherence tomography (OCT) can more frequently disclose
stent edge dissections during percutaneous coronary intervention. The real
frequency and clinical impact of this ﬁnding are still unclear. We analyzed 395 stent
edges from 249 lesions in 230 patients. OCT detected edge dissections in 37.8%
of all lesions. Presence and extent of atherosclerosis and vessel overstretching at
stent edges were independent predictors for dissection occurrence. Additional
stenting was performed in 22.6% of all dissections, which were longer, had bigger
dimensions, and had a deeper degree of vascular injury. The 12-month major
adverse cardiac event rate was similar between patients with (7.95%) and without
(5.69%, p ¼ 0.581) dissections.See additional content in the online version of this issue.(continued on A-26)
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A-26Radial Versus Femoral Access for Primary Percutaneous Interventions in
ST-Segment Elevation Myocardial Infarction Patients: A Meta-Analysis
of Randomized Controlled Trials814Wassef Karrowni, Ankur Vyas, Bria Giacomino, Marin Schweizer, Amy Blevins, Saket Girotra,
Phillip A. Horwitz
The safety and efﬁcacy of radial access compared with femoral access for primary
percutaneous coronary intervention in ST-segment elevation myocardial infarction
patients has been uncertain. We performed a meta-analysis of randomized
controlled trials comparing these 2 approaches. The analysis demonstrated that
compared with femoral access, radial access is associated with decreased risk of
death and major bleeding and with no increased risk of stroke. These ﬁndings
suggest that for transradial skilled operators, the radial access should be the
preferred approach for primary percutaneous coronary intervention.
See additional content in the online version of this issue.EDITORIAL COMMENTRadial Access for ST-Segment Elevation Myocardial Infarction Interventions:
Does It Really Lower Mortality?824Ehtisham Mahmud, Mitul PatelCosts of Transradial Percutaneous Coronary Intervention 827Amit P. Amin, John A. House, David M. Saﬂey, Adnan K. Chhatriwalla, Helmut Giersiefen,
Andreas Bremer, Martial Hamon, Dmitri V. Baklanov, Akinyele Aluko, David Wohns,
David W. Mathias, Robert A. Applegate, David J. Cohen, Steven P. Marso
Contemporary costs of transradial and transfemoral access for percutaneous coro-
nary intervention (PCI) were compared using data from 5 U.S. hospitals. In over
7,000 PCI patients, transradial access was associated with fewer bleeding events and
lower cost from the day of PCI until discharge ($830) than transfemoral access was.
As bleeding risk increased, greater savings were realized in transradial versus
transfemoral patients. According to stepwise regression, 50% of cost savings in
transradial patients were from reduced length of stay, whereas 12% were due to
reduced bleeding. These ﬁndings indicate that transradial PCI access may lower
costs for hospitals.
See additional content in the online version of this issue.EDITORIAL COMMENTThe Value Proposition in Percutaneous Coronary Intervention 835Sunil V. Rao, Manesh R. Patel(continued on A-27)
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A-27Detection by Near-Infrared Spectroscopy of Large Lipid Core Plaques at Culprit Sites
in Patients With Acute ST-Segment Elevation Myocardial Infarction838Ryan D. Madder, James A. Goldstein, Sean P. Madden, Rishi Puri, Kathy Wolski,
Michael Hendricks, Stephen T. Sum, Annapoorna Kini, Samin Sharma, David Rizik,
Emmanouil S. Brilakis, Kendrick A. Shunk, John Petersen, Giora Weisz, Renu Virmani,
Stephen J. Nicholls, Akiko Maehara, Gary S. Mintz, Gregg W. Stone, James E. Muller
Autopsy studies demonstrate that most ST-segment elevation myocardial infarc-
tions (STEMI) are caused by rupture of lipid core plaque. Intracoronary near-
infrared spectroscopy (NIRS) was performed within culprit vessels of STEMI
patients. NIRS identiﬁed signiﬁcantly more lipid core plaque in STEMI culprit
segments than in control segments. Within the STEMI culprit artery, NIRS
accurately distinguished culprit from nonculprit segments. A signature of plaques
causing STEMI has been detected in vivo. These data support a prospective study
to determine if NIRS identiﬁes vulnerable plaques likely to cause future coronary
events.See additional content in the online version of this issue.Impact of Attenuated Plaque as Detected by Intravascular Ultrasound on the
Occurrence of Microvascular Obstruction After Percutaneous Coronary Intervention
in Patients With ST-Segment Elevation Myocardial Infarction847Yasutsugu Shiono, Takashi Kubo, Atsushi Tanaka, Takashi Tanimoto, Shingo Ota,
Yasushi Ino, Hiroshi Aoki, Yuichi Ozaki, Makoto Orii, Kunihiro Shimamura, Kohei Ishibashi,
Takashi Yamano, Tomoyuki Yamaguchi, Kumiko Hirata, Toshio Imanishi, Takashi Akasaka
Microvascular obstruction (MVO) occurs in a sizable proportion of patients with
ST-segment elevation myocardial infarction (STEMI) even after successful
percutaneous coronary intervention (PCI). We assessed the relationship between
the infarct-related lesion morphology by intravascular ultrasound (IVUS) and the
occurrence of MVO by cardiac magnetic resonance imaging in STEMI patients.
Patients with MVO had plaques with greater angle and longer signal attenuation
than those without MVO. Attenuated plaque with a maximum attenuation angle
of >180 and an attenuation length of >5 mm was an independent predictor of
MVO. IVUS might to be a useful tool for risk stratiﬁcation in STEMI patients
undergoing primary PCI.(continued on A-28)
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A-28Clinical Implications of Very Low On-Treatment Platelet Reactivity in Patients
Treated With Thienopyridine: The POBA Study (Predictor of Bleedings With
Antiplatelet Drugs)854Thomas Cuisset, Charlotte Grosdidier, Anderson Diendonné Loundou, Jacques Quilici,
Marie Loosveld, Laurence Camoin, Mathieu Pankert, Shirley Beguin, Marc Lambert,
Pierre Emmanuel Morange, Jean-Louis Bonnet, Marie-Christine Alessi
The present study was designed to deﬁne the very low on-treatment platelet
reactivity (VLTPR) as the most predictive threshold value of platelet reactivity index
vasodilator-stimulated phosphoprotein for the prediction of bleeding events. A total
of 1,542 consecutive patients treated with clopidogrel or prasugrel and undergoing
coronary stenting for acute coronary syndromes were included in the present study.
Of the patients 9% (n ¼ 139) experienced non-access site–related Bleeding
Academic Research Consortium bleeding complications. Receiver-operating char-
acteristic curve analysis identiﬁed very low on-treatment platelet reactivity as platelet
reactivity index vasodilator-stimulated phosphoprotein 10% as the strongest and
independent predictor of bleeding complications in patients treated with
thienopyridines.EDITORIAL COMMENTBleeding and Thrombosis Risk Matters: How Long Can We Stick to the
One-Size-Fits-All Strategy of Platelet Inhibition?864Dirk Sibbing, Lisa Gross, Martin Orban, Steffen MassbergComplete Revascularization Is Not a Prerequisite for Success in Current
Transcatheter Aortic Valve Implantation Practice867Nicolas M. Van Mieghem, Robert M. van der Boon, Elhamula Faqiri, Roberto Diletti,
Carl Schultz, Robert-Jan van Geuns, Patrick W. Serruys, Arie-Pieter Kappetein,
Ron T. van Domburg, Peter P. de Jaegere
Little is known about the prevalence and impact of incomplete coronary revascu-
larization in patients undergoing transcatheter aortic valve implantation (TAVI). In
a single-center cohort of 263 consecutive patients, signiﬁcant coronary artery disease
with myocardium at risk was present in 124 patients (47%). Overall, 99 patients
(37%) (61 with no coronary artery bypass grafting [CABG] patients and 38 CABG
patients) had incomplete revascularization after TAVI. Revascularization status did
not affect clinical endpoints. In an elderly patient population undergoing TAVI for
severe aortic stenosis, a judicious revascularization strategy selection by a dedicated
heart team can generate favorable mid-term outcomes, obviating the need for
complete coronary revascularization.(continued on A-29)
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A-29Survival After Endovascular Therapy in Patients With Type B Aortic Dissection:
A Report From the International Registry of Acute Aortic Dissection (IRAD)876Rossella Fattori, Daniel Montgomery, Luigi Lovato, Stephan Kische, Marco Di Eusanio,
Hüseyin Ince, Kim A. Eagle, Eric M. Isselbacher, Christoph A. Nienaber
Type B acute aortic dissection patients receiving thoracic endovascular aortic repair
(TEVAR) therapy have demonstrated improved in-hospital survival compared with
medical treatment alone, but long-term results of this treatment are relatively
unknown. We accordingly analyzed 1,129 patients from IRAD (the International
Registry of Acute Aortic Dissection) who received medical (n ¼ 853, 75.6%) or
TEVAR (n ¼ 276, 24.4%) therapy. TEVAR patients were more likely to have
complications associated with their dissection. In-hospital (10.9% TEVAR vs. 8.7%
medical, p ¼ 0.273) and 1-year (8.1% TEVAR vs. 9.8% medical, p ¼ 0.604)
mortality rates were similar between groups. Kaplan-Meier estimates of 5-year
survival showed lower mortality among TEVAR patients (15.5% vs. 29.0%,
p ¼ 0.018).See additional content in the online version of this issue.Tissue Uptake, Distribution, and Healing Response After Delivery of Paclitaxel via
Second-Generation Iopromide-Based Balloon Coating: A Comparison With the
First-Generation Technology in the Iliofemoral Porcine Model883Piotr P. Buszman, Armando Tellez, Maxwell E. Afari, Athanasios Peppas, Gerard B. Conditt,
Serge D. Rousselle, Jennifer C. McGregor, Mark Stenoien, Greg L. Kaluza, Juan F. Granada
In the experimental setting, we evaluated the pharmacokinetic proﬁle and vascular
healing response of 2 different generations paclitaxel coated balloon (PCB) coatings.
One-hour tissue uptake in healthy iliofemoral arteries showed a higher and more
uniform (distal to proximal) distribution of paclitaxel in the second-generation PCB
technology. In a familial hypercholesterolemic model of iliofemoral in-stent reste-
nosis both PCBs reduced neointimal hyperplasia equally compared with plain
balloon angioplasty (PBA) by angiography and histology. However, peristrut ﬁbrin
deposits, neointimal maturity, and smooth muscle cell loss were more favorable in
the second-generation PCB group. The clinical implications of these ﬁndings
deserve further investigation.See additional content in the online version of this issue.(continued on A-30)
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A-30891IMAGES IN
INTERVENTIONQuantitative Optical Coherence Tomography Tissue-Type Imaging for Lipid-Core
Plaque DetectionEvelyn Regar, Muthukaruppan Gnanadesigan, Antonius F. W. Van der Steen, Gijs van SoestA New Tool to Manage Side-Branch Occlusion After Covered-Stent Implantation for
Vascular Complications: The Neocarina Reconstruction Technique893Chiara Bernelli, Francesco Maisano, Alaide Chieffo, Matteo Montorfano, Jaclyn Chan,
Davide Maccagni, Antonio ColomboEDITOR’S PAGE The Case for Live Case Demonstrations 895Spencer B. King III
